Literature DB >> 34298240

Design, Hemiysnthesis, crystal structure and anticancer activity of 1, 2, 3-triazoles derivatives of totarol.

Yassine Laamari1, Ali Oubella1, Abdoullah Bimoussa1, Az-Eddine El Mansouri2, El Mostafa Ketatni3, Olivier Mentre4, My Youssef Ait Itto1, Hamid Morjani5, Mostafa Khouili3, Aziz Auhmani6.   

Abstract

A new series of diverse triazoles linked to the hydroxyl group of totarol were synthesized using click chemistry approach. The structures of these compounds were elucidated by HRMS, IR and NMR spectroscopy. The structure of compound 3 g was also confirmed by x-ray single crystal diffraction. The cytotoxicity of these compounds was evaluated by the MTT method against four cancer cell lines, including fibrosarcoma HT-1080, lung carcinoma A-549 and breast adenocarcinoma (MDA-MB-231 and MCF-7), and the results indicated that all compounds showed weak to moderate activities against all cancer cell lines with IC50 values ranging from 14.44 to 46.25 μM. On the basis of our research the structure-activity relationships (SAR) of these compounds were discussed. This work provides some important hints for further structural modification of totarol towards developing novel and highly effective anticancer drugs respectively. It is interesting to note that compound 3 g indicated a very significant cytotoxicity against HT-1080 and A-549 cell lines. The molecular docking showed that compound 3 g activated the caspase-3 and inhibited tubulin by forming stable protein-ligand complexes.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  1,2,3-triazole–totarol hybrids; Apoptosis; Cell cycle; Crystal structure; Cytotoxicity activity; Hirshfeld surface analysis

Mesh:

Substances:

Year:  2021        PMID: 34298240     DOI: 10.1016/j.bioorg.2021.105165

Source DB:  PubMed          Journal:  Bioorg Chem        ISSN: 0045-2068            Impact factor:   5.275


  2 in total

1.  New 1,2,3-Triazoles from (R)-Carvone: Synthesis, DFT Mechanistic Study and In Vitro Cytotoxic Evaluation.

Authors:  Ali Oubella; Abdoullah Bimoussa; Abdellah N'ait Oussidi; Mourad Fawzi; Aziz Auhmani; Hamid Morjani; Abdelkhalek Riahi; M'hamed Esseffar; Carol Parish; Moulay Youssef Ait Itto
Journal:  Molecules       Date:  2022-01-25       Impact factor: 4.411

2.  Synthesis, characterization, molecular docking, and anticancer activities of new 1,3,4-oxadiazole-5-fluorocytosine hybrid derivatives.

Authors:  Az-Eddine El Mansouri; Saida Lachhab; Ali Oubella; Mehdi Ahmad; Johan Neyts; Dirk Jochmans; Winston Chiu; Laura Vangeel; Steven De Jonghe; Hamid Morjani; Mustapha Ait Ali; Mohamed Zahouily; Yogesh S Sanghvi; Hassan B Lazrek
Journal:  J Mol Struct       Date:  2022-09-09       Impact factor: 3.841

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.